A carregar...

Plasma and Cerebrospinal Fluid Pharmacokinetics of Thalidomide and Lenalidomide in Nonhuman Primates

PURPOSE: Thalidomide, originally developed as a sedative, was subsequently identified to have antiangiogenic properties. Lenalidomide is an antiangiogenic and immunomodulatory agent that has been utilized in the treatment of patients with brain tumors. We studied the pharmacokinetics and cerebrospin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Muscal, Jodi A., Sun, Yongkai, Nuchtern, Jed G., Dauser, Robert C., McGuffey, Leticia H., Gibson, Brian W., Berg, Stacey L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3685292/
https://ncbi.nlm.nih.gov/pubmed/22109830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1781-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!